Media

Keep up to date with all the latest news and updates from Virax Biolabs.

 

Virax Biolabs COO, Dr Nigel McCracken, Discusses Immune Decoding with ViraxImmuneTM on the MedTech Gurus Podcast

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Major New Study Reveals Immunological Insights Into ME/CFS, Further Supporting Blood-based Diagnostic Testing and Research

Myalgic encephalomyelitis (ME/CFS), also known as chronic fatigue syndrome, is a complex condition characterized by post-exertional fatigue and a range of neuroimmune symptoms. It is one of several debilitating conditions

ELISA vs ELISpot: Select The Right Assay For Your Research

Immunoassays – such as ELISA and ELISpot – are indispensable tools for immunology research. They work based on principles of antibody-epitope interaction, providing critical insights into the inter- and intracellular

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy.

Diagnosing Long COVID: A Gut-Immune Perspective.

Diagnosing chronic, post-acute inflammatory conditions – like Long COVID – remains a persistent challenge for researchers and healthcare professionals alike. The variable presentation of symptoms – along with the allusivity

Blog post thumbnail: could this be the diagnostic breakthrough we need?

Chronic Illness and The Immune System: Could ViraxImmune™ Offer a Critical Diagnostic Breakthrough?

A recent Wall Street Journal commentary by Yale immunologist Akiko Iwasaki and cardiologist Harlan Krumholz highlights how immune dysfunction following infection may drive a spectrum of chronic diseases—including long COVID,

Nigel McCracken, Virax COO, Discusses the New Frontier in Immune Diagnostics with The Scientist in This Innovation Spotlight.

Virax COO, Nigel McCracken, Exaplains the Latest PAIS IVD Technolgy in His Latest PharmExec.com Interview.

In His Latest PharmExec.com Interview, Virax COO Nigel McCracken Shares New Insights Into the Link Between T Cell Exhaustion and Inflammation in Long-COVID.

Virax COO, Nigel McCracken, Discusses New Data on T Cell Exhaustion in Post-Acute Infection Syndromes with PharmExec.com in Latest Article.

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Read Our Press Release